Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes.

Cardiovasc Diabetol · 2017 · PMC5237274 · PMID 28086951

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The slightly greater gain in lean mass in DbE compared to DbC did not reach statistical significance (Additional file 1 : Figure S1B–E).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.